• 54,806+ CME Conference Registrations Sold
  • 164,417+ Medical Conferences
  • 297 Specialties
  • 11,717 Organizers
  • 159,482 Speakers
  • 159 Countries
  • 4,847 Cities
Duration: CME/CE Points: Faculty:
-
CME : 1.5
Contact Hours : 1.5
CEUs : 0.15
MOC : 1.5
-

Streamlining the Journey to a Cure: Optimizing the Hepatitis C Virus Care Cascade is organized by CME Outfitters, LLC.

Live Webcast: Wednesday, July 8, 2020, | 6:30 PM - 8:00 PM ET
Credit Expiration Date: Thursday, July 8, 2021

This activity offers CE credit for:
•  Physicians (CME)
•  Nurses (CNE)
•  Pharmacists (ACPE)
•  ABIM (MOC)
•  Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™.

Credit Information
CME Credit (Physicians):
CME Outfitters, LLC, is authorized by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, assigns this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians can earn only the credit commensurate with the extent of their participation in the session.

CNE Credit (Nurses):
Provider certified by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs)

ABIM/MOC Credit:
On successful completion of this CME activity, an attendee will be able to apply for the evaluation component, allowing the participant to receive up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will receive MOC points commensurate to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Statement of Need:
Hepatitis C virus (HCV) is a major cause of cirrhosis, liver cancer, and mortality worldwide. The opioid crisis has created a rise in injection drug use, which has contributed significantly to the increase in HCV infections. The United States experienced a 238% increase in new HCV infections between 2010 and 2016, which has led to a goal to eradicate hepatitis by treating 80% of patients with hepatitis B virus (HBV) and HCV by 2030. The American Association for the Study of Liver Diseases/Infectious Disease Society of America (AASLD/IDSA) guidelines strive to accomplish this with the universal, one-time screening of all individuals over 18 for HCV, with individuals at increased risk (e.g., people who inject drugs [PWID]) screened more frequently, as well as universal testing of pregnant women at the initiation of prenatal care.

Once diagnosed, treatment with currently accessible direct-acting antivirals (DAAs) is strongly advised for all persons with chronic HCV infection. However, recent studies have shown persistent gaps in the HCV care continuum, with underdiagnosis and undertreatment being the major barriers toward achieving the goal of eliminating HCV. With primary care clinicians and community health workers representing an important front-line resource for early screening and treatment for HCV infection, it is imperative to educate primary care providers (PCPs) and community health workers to expand the HCV workforce and linkage-to-care opportunities.

These CME Outfitters Live and on-demand webcast will emphasize expert faculty hosting an interactive discussion on implementing HCV screening, developing new methods of coordinated care, and addressing barriers to treatment access.

Learning Objectives:
At the end of this CE activity, attendees should be able to:
• Incorporate HCV screening for all adults and at-risk populations and women including PWID and women who are pregnant, in alignment with AASLD guidance.
• Generate new methods of PCP/specialist coordinated care to minimize gaps in linkage to care and optimize the HCV care cascade.
• Know the barriers to reach to treatment, such as stigma and HCP perceptions about substance use and PWID.

The following learning objectives pertain only to those requesting CNE or CPE credit:
• Describe HCV screening guidelines for all adults and at-risk populations including PWID and women who are pregnant, in alignment with AASLD guidance.
• Recognize distinct methods of PCP/specialist coordinated care to minimize gaps in linkage to care and optimize the HCV care cascade.
• Explain barriers to access to treatment, such as stigma and HCP perceptions about substance use and PWID.

Target Audience

Primary care physicians, PAs, nurse practitioners, nurses, and pharmacists

Fees

Activity Fee : Fee Details will be updated soon
Interested

Specialties

Gastroenterology, Infectious Disease

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.

Recommended